These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3963032)

  • 21. Relative abuse liability of gamma-hydroxybutyric acid, flunitrazepam, and ethanol in club drug users.
    Abanades S; Farré M; Barral D; Torrens M; Closas N; Langohr K; Pastor A; de la Torre R
    J Clin Psychopharmacol; 2007 Dec; 27(6):625-38. PubMed ID: 18004131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The side effect profile of buspirone in comparison to active controls and placebo.
    Newton RE; Casten GP; Alms DR; Benes CO; Marunycz JD
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differing effects of the anxiolytic agents buspirone and diazepam on control of breathing.
    Rapoport DM; Greenberg HE; Goldring RM
    Clin Pharmacol Ther; 1991 Apr; 49(4):394-401. PubMed ID: 1901782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abuse potential of buspirone and related drugs.
    Balster RL
    J Clin Psychopharmacol; 1990 Jun; 10(3 Suppl):31S-37S. PubMed ID: 1973938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abuse liability and clinical pharmacokinetics of alprazolam in alcoholic men.
    Ciraulo DA; Barnhill JG; Greenblatt DJ; Shader RI; Ciraulo AM; Tarmey MF; Molloy MA; Foti ME
    J Clin Psychiatry; 1988 Sep; 49(9):333-7. PubMed ID: 3417618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological effects of buspirone.
    Lader M
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):62-8. PubMed ID: 6130075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans.
    Busto U; Kaplan HL; Zawertailo L; Sellers EM
    Clin Pharmacol Ther; 1994 Apr; 55(4):451-63. PubMed ID: 8162672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diazepam and methadone interactions in methadone maintenance.
    Preston KL; Griffiths RR; Stitzer ML; Bigelow GE; Liebson IA
    Clin Pharmacol Ther; 1984 Oct; 36(4):534-41. PubMed ID: 6478738
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abuse potential of propofol used for sedation in gastric endoscopy and its correlation with subject characteristics.
    Kim JH; Byun H; Kim JH
    Korean J Anesthesiol; 2013 Nov; 65(5):403-9. PubMed ID: 24363842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the novel anxiolytic drug lesopitron, a full and selective 5-HT1A receptor agonist, on pupil diameter and oral temperature in man: comparison with buspirone.
    Phillips MA; Szabadi E; Bradshaw CM
    J Psychopharmacol; 1999 Dec; 13(4):391-7. PubMed ID: 10667616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the Abuse Potential of the Orexin Receptor Antagonist, Suvorexant, Compared With Zolpidem in a Randomized Crossover Study.
    Schoedel KA; Sun H; Sellers EM; Faulknor J; Levy-Cooperman N; Li X; Kennedy WP; Cha JH; Lewis NM; Liu W; Bondiskey P; McCrea JB; Panebianco DL; Troyer MD; Wagner JA
    J Clin Psychopharmacol; 2016 Aug; 36(4):314-23. PubMed ID: 27253658
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative abuse liability and pharmacological effects of meprobamate, triazolam, and butabarbital.
    Zawertailo LA; Busto UE; Kaplan HL; Greenblatt DJ; Sellers EM
    J Clin Psychopharmacol; 2003 Jun; 23(3):269-80. PubMed ID: 12826989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buspirone is differentiated from diazepam in humans using a three-response drug discrimination procedure.
    Frey JM; Mintzer MZ; Rush CR; Griffiths RR
    Psychopharmacology (Berl); 1998 Jul; 138(1):16-26. PubMed ID: 9694522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone.
    Ciraulo DA; Barnhill JG; Ciraulo AM; Sarid-Segal O; Knapp C; Greenblatt DJ; Shader RI
    J Clin Pharmacol; 1997 Jan; 37(1):64-73. PubMed ID: 9048275
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.
    Johnson MW; Suess PE; Griffiths RR
    Arch Gen Psychiatry; 2006 Oct; 63(10):1149-57. PubMed ID: 17015817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Buspirone: multicenter efficacy study.
    Wheatley D
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Buspirone. A preliminary review of its pharmacological properties and therapeutic efficacy as an anxiolytic.
    Goa KL; Ward A
    Drugs; 1986 Aug; 32(2):114-29. PubMed ID: 2874976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of verapamil on morphine-induced euphoria, analgesia and respiratory depression in humans.
    Vaupel DB; Lange WR; London ED
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1386-94. PubMed ID: 8263800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abuse liability assessment of sibutramine, a novel weight control agent.
    Schuh LM; Schuster CR; Hopper JA; Mendel CM
    Psychopharmacology (Berl); 2000 Jan; 147(4):339-46. PubMed ID: 10672626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.